Senores Pharma.

55
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0RB801010
  • NSEID: SENORES
  • BSEID: 544319
INR
1,091.35
-19 (-1.71%)
BSENSE

Nov 20

BSE+NSE Vol: 2.5 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Senores Pharma. Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
No of Months
12
12
12
12
12
Profit Before Tax
159.00
70.00
24.00
12.00
1.00
Adjustment
57.00
27.00
17.00
2.00
1.00
Changes In working Capital
-141.00
-134.00
-66.00
-14.00
-12.00
Cash Flow after changes in Working Capital
75.00
-36.00
-23.00
0.00
-10.00
Cash Flow from Operating Activities
62.00
-45.00
-25.00
-1.00
-10.00
Cash Flow from Investing Activities
-120.00
-429.00
-53.00
-48.00
-24.00
Cash Flow from Financing Activities
-1.00
573.00
86.00
46.00
36.00
Net Cash Inflow / Outflow
-59.00
97.00
7.00
-3.00
1.00
Opening Cash & Cash Equivalents
105.00
7.00
0.00
3.00
1.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
45.00
105.00
7.00
0.00
3.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Senores Pharma.
Markets Mojo
Figures in Cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
159.1
155.11
4.00
2.57%
Adjustment
57.99
37.79
20.00
53.45%
Changes In working Capital
-141.84
-123.69
-18.00
-14.67%
Cash Flow after changes in Working Capital
75.25
69.21
6.00
8.73%
Cash Flow from Operating Activities
62.05
32.06
30.00
93.54%
Cash Flow from Investing Activities
-120.55
-321.51
201.00
62.51%
Cash Flow from Financing Activities
-1.33
299.89
-300.00
-100.44%
Net Cash Inflow / Outflow
-59.83
10.44
-69.00
-673.08%
Opening Cash & Cash Equivalents
105.38
16.95
89.00
521.71%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
45.55
27.38
18.00
66.36%
Cash Flow - Snapshot (Consolidated) - Mar'26
stock-summary

YoY Growth in year ended Mar 2026 is 235.13% vs -78.68% in Mar 2025

Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
62.05
-45.92
235.13%